We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What Analyst Projections for Key Metrics Reveal About Clarivate (CLVT) Q3 Earnings
Read MoreHide Full Article
Wall Street analysts expect Clarivate PLC (CLVT - Free Report) to post quarterly earnings of $0.19 per share in its upcoming report, which indicates a year-over-year decline of 9.5%. Revenues are expected to be $640.01 million, down 1.1% from the year-ago quarter.
The current level reflects a downward revision of 1.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Clarivate metrics that are commonly tracked and forecasted by Wall Street analysts.
It is projected by analysts that the 'Revenues- Intellectual Property' will reach $203.63 million. The estimate indicates a change of -3.8% from the prior-year quarter.
Analysts' assessment points toward 'Revenues- Life Sciences & Healthcare' reaching $104.82 million. The estimate points to a change of -3.2% from the year-ago quarter.
Analysts expect 'Revenues- Academia & Government' to come in at $330.90 million. The estimate suggests a change of +1.1% year over year.
According to the collective judgment of analysts, 'Revenues- Transactional and other revenues' should come in at $106.57 million. The estimate suggests a change of -19.5% year over year.
Based on the collective assessment of analysts, 'Revenues- Re-occurring revenues' should arrive at $111.06 million. The estimate indicates a year-over-year change of +4%.
The combined assessment of analysts suggests that 'Revenues- Subscription revenues' will likely reach $423.25 million. The estimate indicates a year-over-year change of +3.7%.
Shares of Clarivate have experienced a change of -1.2% in the past month compared to the -0.5% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), CLVT is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
What Analyst Projections for Key Metrics Reveal About Clarivate (CLVT) Q3 Earnings
Wall Street analysts expect Clarivate PLC (CLVT - Free Report) to post quarterly earnings of $0.19 per share in its upcoming report, which indicates a year-over-year decline of 9.5%. Revenues are expected to be $640.01 million, down 1.1% from the year-ago quarter.
The current level reflects a downward revision of 1.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Clarivate metrics that are commonly tracked and forecasted by Wall Street analysts.
It is projected by analysts that the 'Revenues- Intellectual Property' will reach $203.63 million. The estimate indicates a change of -3.8% from the prior-year quarter.
Analysts' assessment points toward 'Revenues- Life Sciences & Healthcare' reaching $104.82 million. The estimate points to a change of -3.2% from the year-ago quarter.
Analysts expect 'Revenues- Academia & Government' to come in at $330.90 million. The estimate suggests a change of +1.1% year over year.
According to the collective judgment of analysts, 'Revenues- Transactional and other revenues' should come in at $106.57 million. The estimate suggests a change of -19.5% year over year.
Based on the collective assessment of analysts, 'Revenues- Re-occurring revenues' should arrive at $111.06 million. The estimate indicates a year-over-year change of +4%.
The combined assessment of analysts suggests that 'Revenues- Subscription revenues' will likely reach $423.25 million. The estimate indicates a year-over-year change of +3.7%.
View all Key Company Metrics for Clarivate here>>>
Shares of Clarivate have experienced a change of -1.2% in the past month compared to the -0.5% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), CLVT is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>